Materias dentro de su búsqueda.
Mostrando 1,441 - 1,460 Resultados de 6,219 Para Buscar '"leishmaniasis"', tiempo de consulta: 0.16s Limitar resultados
  1. 1441
    “…BACKGROUND: In Ecuador, cutaneous leishmaniasis (CL) is prevalent countrywide, but only one case of diffuse-CL and two cases of disseminated-CL were experienced during our research activities more than 30 years from 1982 to date. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Diffuse and disseminated cutaneous leishmaniasis: clinical cases experienced in Ecuador and a brief review
  2. 1442
    “…Visceral leishmaniasis (VL) is caused by the protozoan parasite Leishmania donovani. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Differential Role of Leptin as an Immunomodulator in Controlling Visceral Leishmaniasis in Normal and Leptin-Deficient Mice
  3. 1443
    “…The current study was designed to examine the protective efficacy of DNA vaccines based on gp63 and Hsp70 against murine visceral leishmaniasis. Inbred BALB/c mice were immunized subcutaneously twice at an interval of three weeks with pcDNA3.1(+) encoding T cell epitopes of gp63 and Hsp70 individually and in combination. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Immunogenicity and protective efficacy of DNA vaccine against visceral leishmaniasis in BALB/c mice
  4. 1444
    “…Leishmaniasis is caused by parasitic protozoa of the genus Leishmania. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Nonresponsiveness to standard treatment in cutaneous leishmaniasis: A case series from Sri Lanka
  5. 1445
    “…This study primarily aimed to identify the causative species of cutaneous leishmaniasis (CL) in the Khyber Pakhtunkhwa Province of Pakistan and to distinguish any species-specific variation in clinical manifestation of CL. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cutaneous Leishmaniasis in Khyber Pakhtunkhwa Province of Pakistan: Clinical Diversity and Species-Level Diagnosis
  6. 1446
    “…INTRODUCTION: Tegumentary Leishmaniasis (TL) is a neglected, non-contagious, infectious disease, caused by different protozoa species of the Leishmania genus that affects skin and mucous membranes. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Alterations in Evoked Otoacoustic Emissions by the Use of Meglumine Antimoniate in American Tegumentary Leishmaniasis Patients
  7. 1447
    “…Visceral leishmaniasis (VL) is a deadly neglected tropical disease that poses a serious problem in various countries all over the world. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Optimal combinations of control strategies and cost-effective analysis for visceral leishmaniasis disease transmission
  8. 1448
    “…Asymptomatic leishmaniasis may drive the epidemic and an important challenge to reach the goal of joint Visceral Leishmaniasis (VL) elimination initiative taken by three Asian countries. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Asymptomatic leishmaniasis in kala-azar endemic areas of Malda district, West Bengal, India
  9. 1449
    “…INTRODUCTION: Retrospective molecular identification of Leishmania parasites in two patients with visceral leishmaniasis (VL) previously treated in Serbia was carried out. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Retrospective PCR-based species identification of Leishmania in two patients with visceral leishmaniasis in Serbia
  10. 1450
    “…Because of the importance of SALO as a potential component of a leishmaniasis vaccine, a plan to produce this recombinant protein for future scale manufacturing as well as knowledge of its structural characteristics are needed to move SALO forward for the clinical path. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Structure of SALO, a leishmaniasis vaccine candidate from the sand fly Lutzomyia longipalpis
  11. 1451
    “…METHODOLOGY/PRINCIPAL FINDINGS: To assess this hypothesis, sCD163 levels were measured in the serum of leprosy and visceral leishmaniasis (VL) patients stratified by severity of the clinical presentation. sCD163 levels were significantly higher in patients with these diseases than those observed in healthy control individuals. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    sCD163 levels as a biomarker of disease severity in leprosy and visceral leishmaniasis
  12. 1452
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Visceral leishmaniasis complicating idiopathic CD4(+) T-cell lymphocytopenia: 2 case reports
  13. 1453
    “…The diagnosis of cutaneous leishmaniasis was made after histopathologic analysis and polymerase chain reaction essay.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    White starburst-like pattern as a dermoscopic clue in Old World cutaneous leishmaniasis
  14. 1454
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Seroconversion to Lutzomyia intermedia LinB-13 as a biomarker for developing cutaneous leishmaniasis
  15. 1455
    “…Visceral leishmaniasis (VL) remains a major public health problem worldwide. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Anti-parasite therapy drives changes in human visceral leishmaniasis-associated inflammatory balance
  16. 1456
    por Mahmoudi, S, Zaini, F
    Publicado 2015
    “…In addition, the majority of the cases had previously been suspected of leishmaniasis and received treatment. Sporotrichosis is not a well-known condition in Iran and is often misdiagnosed and erroneously treated for other cutaneous parasitic or bacterial infections with similar clinical manifestations. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Sporotrichosis in Iran: A mini review of reported cases in patients suspected to cutaneous leishmaniasis
  17. 1457
    “…BACKGROUND: The determinants of parasite persistence or elimination after treatment and clinical resolution of cutaneous leishmaniasis (CL) are unknown. We investigated clinical and parasitological parameters associated with the presence and viability of Leishmania after treatment and resolution of CL caused by L. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Clinical and parasitological factors in parasite persistence after treatment and clinical cure of cutaneous leishmaniasis
  18. 1458
    “…OBJECTIVE: Cutaneous leishmaniasis (CL) is a significant disease in south-eastern Anatolia because it is prevalent among Syrian refugees. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Genotyping Leishmania promastigotes isolated from patients with cutaneous leishmaniasis in south-eastern Turkey
  19. 1459
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A new perspective on cutaneous leishmaniasis—Implications for global prevalence and burden of disease estimates
  20. 1460
    “…Four species and 2 hybrid strains of Leishmania are pathogenic for humans in the Mediterranean Basin, with an estimated annual incidence of 239,500–393,600 cases of cutaneous leishmaniasis and 1,200–2,000 cases of visceral leishmaniasis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Phlebotomine sand fly–borne pathogens in the Mediterranean Basin: Human leishmaniasis and phlebovirus infections
Herramientas de búsqueda: RSS